Lifirafenib
CAS号 | 1446090-79-4 | 货号 | BCP42783 |
中文名 | Lifirafenib | ||
英文名 | Lifirafenib | ||
中文别名 | |||
英文别名 | BGB-283; BGB 283; BGB283; Beigene-283; | ||
分子式 | C25H17F3N4O3 | 分子量 | 478.42 |
生物活性 | Lifirafenib is an inhibitor of the serine/threonine protein kinase B-raf (BRAF) and epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Lifirafenib selectively binds to and inhibits the activity of BRAF and certain BRAF mutant forms, and EGFR. This prevents BRAF- and EGFR-mediated signaling and inhibits the proliferation of tumor cells that either contain a mutated BRAF gene or express over-activated EGFR. In addition, BGB-283 inhibits mutant forms of the Ras proteins K-RAS and N-RAS. BRAF and EGFR are mutated or upregulated in many tumor cell types. | ||
信号通路 | MAPK Pathway | ||
靶 点 | Raf |
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服:
- 全国免费电话:400-099-8200
瀚香生物(Biochempartner) 的所有产品和服务仅用于科学研究,禁止用于人体和治疗!